Clinitech Laboratory Ltd

Clinitech Laboratory Ltd

₹ 38.0 0.53%
10 Jun - close price
About

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.[1]

Key Points

Business Overview:[1]
CTLL in the business of providing NABL
accredited healthcare services such as:
a) Pathology testing labs
b) Diagnostic centres
c) Scan centres
d) X-ray centres
e) ECG clinics

  • Market Cap 8.68 Cr.
  • Current Price 38.0
  • High / Low 57.0 / 28.6
  • Stock P/E 20.7
  • Book Value 40.5
  • Dividend Yield 0.00 %
  • ROCE 7.20 %
  • ROE 4.65 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.94 times its book value
  • Promoter holding has increased by 1.78% over last quarter.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Sep 2025 Mar 2026
4.16 5.08 4.41
3.88 4.54 3.96
Operating Profit 0.28 0.54 0.45
OPM % 6.73% 10.63% 10.20%
0.17 0.11 0.08
Interest 0.02 0.05 0.02
Depreciation 0.14 0.25 0.26
Profit before tax 0.29 0.35 0.25
Tax % 41.38% 14.29% 52.00%
0.17 0.30 0.12
EPS in Rs 0.74 1.31 0.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
8.23 9.49
7.40 8.50
Operating Profit 0.83 0.99
OPM % 10.09% 10.43%
0.23 0.19
Interest 0.06 0.07
Depreciation 0.45 0.51
Profit before tax 0.55 0.60
Tax % 29.09% 30.00%
0.39 0.42
EPS in Rs 1.71 1.84
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 5%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 2.28 2.28
Reserves 6.55 6.97
0.00 0.54
2.01 1.39
Total Liabilities 10.84 11.18
3.13 3.17
CWIP 0.00 0.26
Investments 0.07 0.07
7.64 7.68
Total Assets 10.84 11.18

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
-0.88 -0.79
-0.73 -0.68
3.98 0.51
Net Cash Flow 2.37 -0.96
Free Cash Flow -1.73 -1.60
CFO/OP -87% -59%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Debtor Days 68.30 71.15
Inventory Days 124.01 117.90
Days Payable 177.82 77.52
Cash Conversion Cycle 14.48 111.53
Working Capital Days 114.87 158.85
ROCE % 7.20%

Insights

In beta
Mar 2024 Mar 2025
Clinical Test Receipts Revenue (Proxy for Volume)
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Debtors Turnover Ratio
Times ・Standalone data
Number of Permanent Employees
Count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

18 Recently
Sep 2024Mar 2025Sep 2025Mar 2026
61.58% 61.58% 62.42% 64.21%
0.32% 0.32% 0.32% 0.32%
38.11% 38.11% 37.27% 35.49%
No. of Shareholders 346303303297

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents